610 Journal of Natural Products, 2006, Vol. 69, No. 4
Deyrup et al.
6-Hydroxypunctaporonin E (1): white powder; [R]25D -20 (c 0.08,
CH3OH); HPLC tR 14.7 min under the above conditions; UV (CH3-
OH) λmax (log ꢀ) 201 (3.38); IR (KBr) νmax 3401, 2918, 1630, 1384,
1095, 1046 cm-1; 1H NMR, 13C NMR, HMBC, and NOESY data, see
Table 1; EIMS (70 eV) m/z 250 (M - H2O; rel int 2), 232 (3), 219 (5),
194 (42), 176 (12), 163 (16), 150 (49), 125 (100), 107 (53), 91 (62),
55 (75); HRESIMS m/z 267.1599 [M - H]-, calcd for C15H23O4,
267.1596.
and the C-2 proton is 12 Hz. Similar HMQC correlations were
observed in 1 and 2, therefore resulting in a similar adjustment in
the corresponding assignments for punctaporonins A, B, and E.
Literature descriptions of the biological activity of the puncta-
poronins have varied from “of little interest”14 to “remarkable”.15
Compounds 1 and 2 exhibited activity in standard agar disk
diffusion assays16,17 at 100 µg/disk against Bacillus subtilis (ATCC
6051), each causing a 12-mm zone of inhibition. Staphylococcus
aureus (ATCC 29213) was inhibited to a lesser extent by 1 and 2,
the zone being 8 mm in both cases. No activity was observed for
3 against B. subtilis or S. aureus. All three compounds were for
inactive in assays against Escherichia coli (ATCC 25922) and
Candida albicans (ATCC 14053) at 100 µg/disk or against
Aspergillus flaVus (NRRL 6541) and Fusarium Verticillioides
(NRRL 25457) at 200 µg/disk.
6-Hydroxypunctaporonin B (2): colorless glass; [R]25 -80 (c
D
0.08, CH3OH); HPLC tR 28.5 min under the above conditions; UV
(CH3OH) λmax (log ꢀ) 198 (3.62) 206 (3.51); IR (KBr) νmax 3414, 2932,
1
1705, 1642, 1384, 1120, 1065 cm-1; H NMR (CDCl3, 300 MHz) δ
5.87 (1H, d, J ) 2.2 Hz, H-11), 5.72 (1H, d, J ) 13 Hz, H-9), 5.63
(1H, ddd, J ) 13, 2.2, 2.1 Hz, H-10), 4.12 (1H, dd, J ) 11, 2.1 Hz,
H-12a), 4.02 (1H, d, J ) 4.8 Hz, H-6), 3.88 (1H, d, J ) 11 Hz, H-12b),
3.35 (1H, dd, J ) 12, 8.2 Hz, H-2), 2.82 (1H, dd, J ) 16, 4.8 Hz,
H-7a), 2.15 (1H, dd, J ) 12, 10 Hz, H-3a), 1.54 (1H, dd, J ) 10, 8.2
Hz, H-3b), 1.41 (1H, d, J ) 16 Hz, H-7b), 1.26 (3H, s, H3-13), 1.24
(3H, s, H3-15), 1.10 (3H, s, H3-14); 13C NMR (CDCl3, 75 MHz) δ
141.2 (d, C-9), 138.2 (s, C-1), 127.8 (d, C-11), 124.4 (d, C-10), 82.7
(s, C-5), 74.2 (s, C-8), 71.8 (d, C-6), 65.1 (t, C-12), 46.9 (t, C-7), 40.4
(s, C-4), 39.2 (d, C-2), 33.7 (t, C-3), 32.5 (q, C-15), 24.6 (q, C-13),
23.8 (q, C-14); HMBC (acetone-d6, 600 MHz) H-2 f C-1, 3, 4, 5, 6,
11, 12; H-3a f C-1, 2, 4, 5, 13, 14; H-3b f C-2, 4, 5, 6, 13; H-6 f
C-8; H-7a f C-5, 6, 8, 9, 15; H-7b f C-5, 6, 8, 9, 15; H-9 f C-1, 7,
11; H-10 f C-1, 8; H-11 f C-1, 2, 5, 9, 10, 12; H-12a f C-1, 2, 11;
H-12b f C-1, 2, 11; H3-13 f C-3, 4, 5, 14; H3-14 f C-3, 4, 5, 13;
H3-15 f C-7, 8, 9; NOESY (acetone-d6, 400 MHz) H-2 f H-3b, 6,
10, 13; H-3a f H-3b, 12a, 12b, 14; H-3b f H-2, 3a, 12a, 12b, 13;
H-6 f H-2, 7a, 7b, 13; H-7a f H-6, 7b, 11, 15; H-7b f H-6, 7a; H-9
f H-15; H-10 f H-2; H-11 f H-7a, 12b, 15; H-12a f H-3a, 12b;
H-12b f H-3a, 11, 12a; H3-13 f H-2, 6; H3-14 f H-3a; H3-15 f
H-7a, 9, 11; EIMS (70 eV) m/z 250 (M - H2O; rel int 1), 232 (4), 217
(4), 204 (18), 175 (9), 161 (16), 147 (17), 131 (48), 107 (60), 91 (83),
55 (100); HRESIMS m/z 267.1594 [M - H]-, calcd for C15H23O4,
267.1596.
Experimental Section
General Experimental Procedures. Optical rotations were mea-
sured with a Rudolph Research Autopol III automatic polarimeter. UV
measurements were performed with a Varian Cary 100 Bio UV-vis
spectrophotometer. IR measurements employed a Perkin-Elmer Spec-
1
trum BX FT-IR instrument. H and 13C NMR spectra were recorded
on either a Bruker AC-300 or a DPX-300 spectrometer. NOESY data
were recorded on a Bruker DRX-400. HMBC and HMQC experiments
were performed on a Bruker AMX-600 spectrometer. Chemical shift
values were referenced to residual solvent signals as follows (δH/δC):
acetone-d6 (2.05/29.8), CDCl3 (7.24/77.0), CD3OD (3.30/49.0). ESIMS
and HRESIMS data were recorded on a Micromass Autospec instru-
ment, and EIMS (70 eV) data were obtained using a Finnigan Voyager
instrument.
Fungal Material. Stromata of an unidentified pyrenomycete growing
on a dead hardwood branch in a hardwood swamp within Reed
Bingham State Park, Adel, GA, were collected by B. W. Horn on April
29, 2000. The stromata, along with portions of the woody substrate on
which the stromata had formed, were placed in plastic bags and stored
at 5 °C. To isolate microfungal colonists, stromatal surfaces were gently
abraded with a surface-sterilized fingernail file to remove portions of
the blackened tissues. Direct plating of stromatal filings was ac-
complished by sprinkling a small portion (100-200 mg) of the filings
over the surface of each of two plates of dextrose-peptone-yeast extract
agar (DPYA) containing streptomycin (25 mg/L) and tetracycline (1.25
mg/L).18 Plates were incubated in the dark at 25 °C for 5 days, and
representative cultures were isolated from each colony type showing a
distinctive morphology on DPYA. After 7-12 days incubation, the
tube cultures isolated from the stromatal filings were segregated into
groups of presumptive species and maintained for identification and
rice fermentation (25 °C).
One of these cultures, MYC-1444, was determined by D.T.W. to
be an isolate of Pestalotiopsis disseminata (Thuemen) Steyaert. A
subculture of this organism was deposited in the ARS collection at the
USDA National Center for Agricultural Utilization Research in Peoria,
IL, with the accession number NRRL 36915.
Fermentation was carried out in a single 500-mL Erlenmeyer flask
containing 50 g of rice. Distilled H2O (50 mL) was added to the flask,
and the contents were soaked overnight before autoclaving at 15 lb/
in.2 for 30 min. The flask was cooled to room temperature, inoculated
with 3.0 mL of spore inoculum, and incubated for 30 days at 25 °C.
After incubation, the fermented rice substrate was mechanically
fragmented and then extracted repeatedly with EtOAc (3 × 100 mL).
The combined EtOAc extracts were filtered and evaporated to give a
yellow oil (419 mg).
6-Hydroxypunctaporonin A (3): white powder; [R]25D -11 (c 0.07,
CH3OH); HPLC tR 18.1 min under the above conditions; UV (CH3-
OH) λmax (log ꢀ) 202 (3.38); IR (KBr) νmax 3394, 2926, 1632, 1384,
1088, 1020 cm-1; 1H NMR (CD3OD, 300 MHz) δ 5.70 (2H, br s, H-10
and H-11), 4.18 (1H, dd, J ) 9.7, 5.2 Hz, H-6), 4.07 (1H, s, H-9),
3.69 (1H, d, J ) 10.5 Hz, H-12a), 3.46 (1H, d, J ) 10.5 Hz, H-12b),
2.38 (1H, dd, J ) 12, 7.5 Hz, H-2), 2.06 (1H, dd, J ) 12, 7.6 Hz,
H-3a), 1.91 (1H, dd, J ) 13, 5.2 Hz, H-7a), 1.63 (1H, dd, J ) 13, 9.7
Hz, H-7b), 1.53 (1H, dd, J ) 7.6, 7.5 Hz, H-3b), 1.19 (3H, s, H3-13),
1
1.12 (3H, s, H3-14), 1.02 (3H, s, H3-15); H NMR data for 3 were
recorded in both acetone-d6 and CD3OD because the olefinic signals
were fortuitously overlapping in CD3OD, but acetone-d6 obscured the
signal at δ 2.06; 13C NMR (CD3OD, 75 MHz) δ 142.3 (d, C-11), 130.6
(d, C-10), 88.4 (d, C-9), 81.1 (s, C-5), 70.1 (d, C-6), 62.6 (t, C-12),
55.6 (s, C-1), 50.9 (s, C-8), 48.1 (d, C-2), 43.1 (s, C-4), 41.0 (t, C-7),
35.9 (t, C-3), 24.7 (q, C-15), 24.3 (q, C-14), 23.5 (q, C-13); HMBC
(acetone-d6, 600 MHz) H-2 f C-1, 3, 4, 5, 6, 8, 11, 12; H-3a f C-1,
2, 4, 5, 13, 14; H-3b f C-2, 4, 5, 6, 13, 14; H-6 f C-5, 7; H-7a f
C-1, 4, 5, 6, 8, 9, 15; H-7b f C-5, 6, 8, 9, 15; H-9 f C-1, 10, 11, 15;
H-10 f C-1, 8, 9, 11; H-11 f C-1, 8, 9, 10, 12; H-12a f C-1, 2, 8,
11; H-12b f C-1, 2, 8, 11; H3-13 f C-3, 4, 5, 14; H3-14 f C-3, 4, 5,
13; H3-15 f C-1, 7, 8, 9; NOESY (CDCl3, 400 MHz) H-2 f H-3b, 6,
13; H-3a f H-3b, 12a, 14; H-3b f H-3a; H-6 f H-2, 7a, 13; H-7a f
H-6, 7b, 15; H-7b f H-7a, 15; H-9 f H-7a, 15; H-12a f H-3a, 12b;
H-12b f H-12a, 15; H3-13 f H-6; H3-14 f H-3a; H3-15 f H-7a, 7b,
9, 12b; overlap of H-10 and H-11 prevented unambiguous assignment
of NOESY correlations for those signals; EIMS (70 eV) m/z 250 (M
- H2O; rel int 2), 237 (23), 219 (18), 194 (37), 181 (90), 163 (100),
145 (49), 135 (78), 107 (57), 91 (92), 55 (98); HRESIMS m/z 267.1587
[M - H]-, calcd for C15H23O4, 267.1596.
12-(4-Bromobenzoyl)-6-hydroxypunctaporonin E (4): A sample
of 1 (6.0 mg) was dissolved in dry THF and added to a 10-mL round-
bottom flask. To the flask were added 2.7 mg of DMAP and 5.4 mg of
4-bromobenzoyl chloride. Three milliliters of dry CH2Cl2 was added
to aid in the dissolution of the reagents. The reaction vessel was sealed
under an Ar atmosphere and stirred at room temperature for 168 h.
Purification was carried out by reversed-phase HPLC (Beckman
Ultrasphere, semipreparative C-18 5-µm column, 1.0 × 25 cm, 2 mL/
min) with a linear gradient from 20 to 100% CH3CN in water over 40
Isolation of 1-3. The EtOAc extract (419 mg) was partitioned
between hexanes and CH3CN. The CH3CN phase (384 mg) was then
fractionated on a silica gel column, eluting successively with 100%
CH2Cl2, 98:2 CH2Cl2-CH3OH, 95:5 CH2Cl2-CH3OH, 90:10 CH2Cl2-
CH3OH, and 80:20 CH2Cl2-CH3OH, and 20-mL fractions were
collected. Compounds 1, 2, and 3 were present in the 15th fraction (74
mg), eluting at 90:10 CH2Cl2-CH3OH. They were separated by
preparative reversed-phase HPLC (Rainin Dynamax, C-18 column, 2.0
× 30 cm, 10 mL/min) using 20% CH3CN in water for 25 min, followed
by a linear gradient from 20 to 60% CH3CN over 15 min to afford 1
(20 mg), 2 (9 mg), and 3 (12 mg).